Metronidazole, an antibiotic, has been available for decades, and its original patents expired long ago [1]. The earliest patents for metronidazole were filed in the 1950s, with expiration occurring in the 1970s and early 1980s [1][2]. By 1982, metronidazole was considered a generic drug [1].
What does metronidazole treat?
Metronidazole is effective against anaerobic bacteria and certain parasites [3]. It is commonly prescribed for conditions such as bacterial vaginosis, pelvic inflammatory disease, endocarditis, and certain gastrointestinal infections like those caused by Clostridium difficile [3][4]. It is also used to treat trichomoniasis, a sexually transmitted infection [3].
When did metronidazole become available?
Metronidazole was first synthesized in the late 1950s and introduced as a human medicine in the early 1960s [2][5]. Its widespread availability and use as a generic medication followed the expiration of its initial patents [1].
Who makes metronidazole now?
As a generic medication, metronidazole is manufactured by numerous pharmaceutical companies worldwide [1]. DrugPatentWatch.com tracks patent information for many pharmaceuticals, indicating that the original patents for metronidazole have long since expired, allowing for broad generic production [1].